| scholarly article | Q13442814 |
| P2093 | author name string | Jun He | |
| Edward P Morris | |||
| Paula C A da Fonseca | |||
| P433 | issue | 1 | |
| P304 | page(s) | 54-66 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Molecular model of the human 26S proteasome | |
| P478 | volume | 46 |
| Q39005586 | A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction |
| Q36579541 | ATP binding by proteasomal ATPases regulates cellular assembly and substrate-induced functions of the 26 S proteasome |
| Q27720380 | An atomic structure of the human 26S proteasome |
| Q27933155 | An inducible chaperone adapts proteasome assembly to stress |
| Q37086118 | Architecture of human translation initiation factor 3. |
| Q38090856 | Assembly of the 20S proteasome. |
| Q36512285 | Atomic model of the human cardiac muscle myosin filament. |
| Q28238443 | Autoregulation of the 26S proteasome by in situ ubiquitination |
| Q35626302 | Base-CP proteasome can serve as a platform for stepwise lid formation |
| Q33607221 | Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome. |
| Q27027816 | Building and remodelling Cullin-RING E3 ubiquitin ligases |
| Q28115049 | CSNAP Is a Stoichiometric Subunit of the COP9 Signalosome |
| Q27026110 | Chaperone machines for protein folding, unfolding and disaggregation |
| Q35351570 | Chaperone-mediated 26S proteasome remodeling facilitates free K63 ubiquitin chain production and aggresome clearance |
| Q27026945 | Characterizing the dynamics of proteasome complexes by proteomics approaches |
| Q26738752 | Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview |
| Q40130408 | Conformational Landscape of the p28-Bound Human Proteasome Regulatory Particle. |
| Q28292908 | Conformational switching of the 26S proteasome enables substrate degradation |
| Q26765684 | Cross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease |
| Q41604784 | Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core. |
| Q59060928 | Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome |
| Q27694578 | Crystal structure of the human COP9 signalosome |
| Q35093980 | Deciphering preferential interactions within supramolecular protein complexes: the proteasome case |
| Q36536393 | Design principles of a universal protein degradation machine |
| Q42378494 | Detection of active proteasome structures in brain extracts: proteasome features of August rat brain with violations in monoamine metabolism |
| Q38125278 | Deubiquitylases from genes to organism |
| Q92110580 | Developments, applications, and prospects of cryo-electron microscopy |
| Q27935947 | Disassembly of Lys11 and mixed linkage polyubiquitin conjugates provides insights into function of proteasomal deubiquitinases Rpn11 and Ubp6. |
| Q30887503 | Do's and don'ts of cryo-electron microscopy: a primer on sample preparation and high quality data collection for macromolecular 3D reconstruction |
| Q37603509 | E2-25K SUMOylation inhibits proteasome for cell death during cerebral ischemia/reperfusion |
| Q38237803 | Emerging mechanistic insights into AAA complexes regulating proteasomal degradation |
| Q36293871 | FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing. |
| Q44015001 | Formation of alternative proteasomes: same lady, different cap? |
| Q26996345 | Functions of the 19S complex in proteasomal degradation |
| Q28066287 | Fundamental Characteristics of AAA+ Protein Family Structure and Function |
| Q45229028 | Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system |
| Q35862786 | Gates, Channels, and Switches: Elements of the Proteasome Machine |
| Q36339269 | Go hybrid: EM, crystallography, and beyond |
| Q38177328 | Harnessing proteasome dynamics and allostery in drug design. |
| Q36392578 | High-resolution cryo-EM proteasome structures in drug development. |
| Q39010593 | High-resolution cryo-EM structure of the proteasome in complex with ADP-AlFx |
| Q37644283 | Human eIF3: from 'blobology' to biological insight. |
| Q40818062 | IBiSS, a versatile and interactive tool for integrated sequence and 3D structure analysis of large macromolecular complexes |
| Q36916869 | Identification of proteasome subunit beta type 6 (PSMB6) associated with deltamethrin resistance in mosquitoes by proteomic and bioassay analyses |
| Q34398136 | Inherent asymmetry in the 26S proteasome is defined by the ubiquitin receptor RPN13 |
| Q34438593 | Intrinsically disordered segments affect protein half-life in the cell and during evolution |
| Q28661264 | Invited review article: Methods for imaging weak-phase objects in electron microscopy |
| Q41730755 | Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice |
| Q38114768 | Mitochondrial matrix proteases as novel therapeutic targets in malignancy. |
| Q57046926 | Modeling Biological Rhythms in Cell Populations |
| Q33912642 | Modelling proteasome and proteasome regulator activities. |
| Q46188514 | Molecular Details Underlying Dynamic Structures and Regulation of the Human 26S Proteasome. |
| Q27693890 | Molecular architecture and assembly of the eukaryotic proteasome |
| Q38268491 | Moonlighting and pleiotropy within two regulators of the degradation machinery: the proteasome lid and the CSN. |
| Q38632963 | Natural products against hematological malignancies and identification of their targets |
| Q30524942 | Near-atomic resolution structural model of the yeast 26S proteasome. |
| Q35120022 | Nonproteolytic roles of 19S ATPases in transcription of CIITApIV genes |
| Q39234159 | Novel Proteasome Inhibitors and Histone Deacetylase Inhibitors: Progress in Myeloma Therapeutics |
| Q45985420 | Nuclear genes with sex bias in Ruditapes philippinarum (Bivalvia, veneridae): Mitochondrial inheritance and sex determination in DUI species. |
| Q34785777 | Nuclear transport of yeast proteasomes |
| Q42320401 | Nucleotide-dependent switch in proteasome assembly mediated by the Nas6 chaperone |
| Q33912635 | PA28αβ: the enigmatic magic ring of the proteasome? |
| Q90618691 | PSMC2 is Up-regulated in Pancreatic Cancer and Promotes Cancer Cell Proliferation and Inhibits Apoptosis |
| Q37702385 | PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration |
| Q93025278 | PSMD12 haploinsufficiency in a neurodevelopmental disorder with autistic features |
| Q34410240 | Paradigms of protein degradation by the proteasome |
| Q40451741 | Proteasome Activation is Mediated via a Functional Switch of the Rpt6 C-terminal Tail Following Chaperone-dependent Assembly. |
| Q28245575 | Proteasome assembly |
| Q86573364 | Proteasome assembly from 15S precursors involves major conformational changes and recycling of the Pba1-Pba2 chaperone |
| Q38202977 | Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma |
| Q92923068 | Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer |
| Q47098533 | Proteasomes in Protein Homeostasis of Pluripotent Stem Cells |
| Q26801512 | Protein Folding and Mechanisms of Proteostasis |
| Q34016160 | Proteomic analysis of Apis cerana and Apis mellifera larvae fed with heterospecific royal jelly and by CSBV challenge |
| Q50460036 | Quantitative live-cell imaging reveals spatio-temporal dynamics and cytoplasmic assembly of the 26S proteasome |
| Q26738716 | Recent advances in the structural biology of the 26S proteasome |
| Q39256977 | Recombinant expression, reconstitution and structure of human anaphase-promoting complex (APC/C). |
| Q35257872 | Regulated protein turnover: snapshots of the proteasome in action |
| Q90673658 | Regulation of proteasome assembly and activity in health and disease |
| Q36642966 | Selective Binding of AIRAPL Tandem UIMs to Lys48-Linked Tri-Ubiquitin Chains |
| Q35537724 | Single-Particle Cryo-EM at Crystallographic Resolution |
| Q36833345 | Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis |
| Q28542494 | Structural and biochemical characterization of the Cop9 signalosome CSN5/CSN6 heterodimer |
| Q36988986 | Structural basis for a reciprocal regulation between SCF and CSN. |
| Q37469477 | Structural basis for dynamic regulation of the human 26S proteasome |
| Q38081952 | Structural biology of the proteasome |
| Q37396451 | Structural insights into proteasome activation by the 19S regulatory particle |
| Q34629636 | Structural insights into the mechanism of phosphoregulation of the retinoblastoma protein |
| Q53831231 | Structural mechanism for nucleotide-driven remodeling of the AAA-ATPase unfoldase in the activated human 26S proteasome. |
| Q41984174 | Structural propensities of human ubiquitination sites: accessibility, centrality and local conformation. |
| Q52322457 | Structure and Function of the 26S Proteasome. |
| Q51035419 | Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism. |
| Q90207565 | Structure of E3 ligase E6AP with a proteasome-binding site provided by substrate receptor hRpn10 |
| Q36684717 | Structure of an endogenous yeast 26S proteasome reveals two major conformational states |
| Q37102327 | Structure of the human 26S proteasome at a resolution of 3.9 Å. |
| Q41429616 | Structure of ubiquitylated-Rpn10 provides insight into its autoregulation mechanism. |
| Q36666357 | Subcellular distribution and dynamics of active proteasome complexes unraveled by a workflow combining in vivo complex cross-linking and quantitative proteomics. |
| Q35538460 | TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities |
| Q34261453 | The 19S proteasome activator promotes human cytomegalovirus immediate early gene expression through proteolytic and nonproteolytic mechanisms |
| Q87608311 | The JAMM in the proteasome |
| Q33361879 | The Role of Proteases in Hippocampal Synaptic Plasticity: Putting Together Small Pieces of a Complex Puzzle |
| Q38122985 | The complexity of recognition of ubiquitinated substrates by the 26S proteasome |
| Q38615247 | The devil is in the details: comparison between COP9 signalosome (CSN) and the LID of the 26S proteasome |
| Q64166842 | The immunoproteasome and thymoproteasome: functions, evolution and human disease |
| Q53834188 | The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S. |
| Q36451967 | The organization of a CSN5-containing subcomplex of the COP9 signalosome |
| Q33673764 | The proteasome complex and the maintenance of pluripotency: sustain the fate by mopping up? |
| Q34623947 | The proteasome under the microscope: the regulatory particle in focus |
| Q37226121 | The proteasome-associated protein Ecm29 inhibits proteasomal ATPase activity and in vivo protein degradation by the proteasome |
| Q92432626 | The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis |
| Q28082910 | Trial Watch: Proteasomal inhibitors for anticancer therapy |
| Q38559265 | Tuning the proteasome to brighten the end of the journey |
| Q91983592 | Two alternative mechanisms regulate the onset of chaperone-mediated assembly of the proteasomal ATPases |
| Q90365039 | Ubiquitin-dependent switch during assembly of the proteasomal ATPases mediated by Not4 ubiquitin ligase |
| Q36760210 | Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle |
| Q44277173 | Ultrastructural pathology and interorganelle cross talk in hepatotoxicity |
| Q36799938 | Uncommon functional properties of the first piscine 26S proteasome from the Antarctic notothenioid Trematomus bernacchii |
| Q38333809 | Understanding the structural basis for controlling chromosome division |
| Q41572915 | Unusual Antioxidant Properties of 26S Proteasome Isolated from Cold-Adapted Organisms. |
Search more.